MIR29B regulates expression of MLLT11 (AF1Q), an MLL fusion partner, and low MIR29B expression associates with adverse cytogenetics and poor overall survival in AML

MLLT11, an MLL fusion partner, is a poor prognostic biomarker for paediatric acute myeloid leukaemia (AML), adult normal cytogenetics AML, and adult myelodysplastic syndrome. MLLT11 is highly regulated during haematopoietic progenitor differentiation and development but its regulatory mechanisms hav...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Xiong, Yin, Li, Zejuan, Ji, Min, Tan, Aik-Choon, Bemis, Judson, Tse, Jove-Victor, Huang, Gang, Park, Jino, Ji, Chunyan, Chen, Jianjun, Bemis, Lynne T., Bunting, Kevin D., Tse, William
Format: Artigo
Langue:Inglês
Publié: 2011
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3896048/
https://ncbi.nlm.nih.gov/pubmed/21496004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2011.08662.x
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires